메뉴 건너뛰기




Volumn 5, Issue , 2006, Pages 453-487

Chemical stability

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84906460472     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter
Times cited : (5)

References (46)
  • 9
    • 0004135189 scopus 로고
    • Lea & Febiger: Philadelphia, PA
    • Martin, A. Physical Pharmacy; Lea & Febiger: Philadelphia, PA, 1993; pp 305-316.
    • (1993) Physical Pharmacy; , pp. 305-316
    • Martin, A.1
  • 18
    • 62349102304 scopus 로고    scopus 로고
    • Drug Racemization and Its Significance in Pharmaceutical Research
    • In, Stereochemical Aspects of Drug Action and Disposition; Eichelbaum, M., Testa, B., Somogyi, A., Eds.; Springer Verlag: Berlin, Germany
    • Reist, M.; Testa, B.; Carrupt, P A. Drug Racemization and Its Significance in Pharmaceutical Research. In Handbook of Experimental Pharmacology, Vol. 153, Stereochemical Aspects of Drug Action and Disposition; Eichelbaum, M., Testa, B., Somogyi, A., Eds.; Springer Verlag: Berlin, Germany, 2003, pp 91-122.
    • (2003) Handbook of Experimental Pharmacology , vol.153 , pp. 91-122
    • Reist, M.1    Testa, B.2    Carrupt, P.A.3
  • 20
    • 85081484250 scopus 로고    scopus 로고
    • US Department of Health and Human Services, Food and Drug Adminstration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), ICH, August, Revision 1, Guidance for Industry, Q1A Stability Testing of New Drug Substances and Products
    • US Department of Health and Human Services, Food and Drug Adminstration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), ICH, August 2001, Revision 1, http://www.fda.gov/cder/guidance/4282fnl.htm, Guidance for Industry, Q1A Stability Testing of New Drug Substances and Products.
    • (2001)
  • 21
    • 85081475643 scopus 로고    scopus 로고
    • US Department of Health and Human Services, Food and Drug Adminstration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), ICH, November, Guidance for Industry, Q1B Photostability Testing of New Drug Substances and Products
    • US Department of Health and Human Services, Food and Drug Adminstration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), ICH, November 1996, http://www.fda.gov/cder/guidance/1318.htm, Guidance for Industry, Q1B Photostability Testing of New Drug Substances and Products.
    • (1996)
  • 22
    • 79959565230 scopus 로고    scopus 로고
    • Stability Studies
    • In, ; Ahuja, S., Scypinski, S., Eds.; Academic Press: San Diego, CA
    • Cha, J.; Ranweiler, J. S.; Lane, P A. Stability Studies. In Handbook of Modern Pharmaceutical ; Ahuja, S., Scypinski, S., Eds.; Academic Press: San Diego, CA, 2001, pp 445-483.
    • (2001) Handbook of Modern Pharmaceutical , pp. 445-483
    • Cha, J.1    Ranweiler, J.S.2    Lane, P.A.3
  • 29
    • 85081483313 scopus 로고    scopus 로고
    • Presented at 3rd Annual Symposium on Chemical and Pharmaceutical Structure Analysis, Princeton, NJ, Sept 26-28
    • Kerns, E. H. Presented at 3rd Annual Symposium on Chemical and Pharmaceutical Structure Analysis, Princeton, NJ, Sept 26-28, 2000.
    • (2000)
    • Kerns, E.H.1
  • 34
    • 33745890994 scopus 로고    scopus 로고
    • How Do We Study Oxidative Chemical Stability in Discovery? Some Ideas, Trials and Outcomes
    • In, Borchardt, R., Kerns, E. H., Lipinski, C. A., Thakker, D. R., Wang, B., Eds.; AAPS Press: Arlington, VA
    • Lombardo, F; Campos, G. How Do We Study Oxidative Chemical Stability in Discovery? Some Ideas, Trials and Outcomes. In Pharmaceutical Profiling in Drug Discovery for Lead Selection; Borchardt, R., Kerns, E. H., Lipinski, C. A., Thakker, D. R., Wang, B., Eds.; AAPS Press: Arlington, VA, 2004, pp 183-194.
    • (2004) Pharmaceutical Profiling in Drug Discovery for Lead Selection; , pp. 183-194
    • Lombardo, F.1    Campos, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.